View in EDS HTML Full Text PDF Full Text

Long‐Term Safety and Efficacy of Crisugabalin for Diabetic Peripheral Neuropathic Pain: A 52‐Week, Multicenter, Single‐Arm Trial.

Saved in:
Bibliographic Details
Title: Long‐Term Safety and Efficacy of Crisugabalin for Diabetic Peripheral Neuropathic Pain: A 52‐Week, Multicenter, Single‐Arm Trial.
Authors: Guo, Xiaohui1 (AUTHOR) bdyyguoxiaohui@sina.com, Wang, Kailiang2 (AUTHOR), Zhang, Tingting1 (AUTHOR), Ma, Jianhua3 (AUTHOR), Li, Yukun4 (AUTHOR), Jiang, Chengxia5 (AUTHOR), Liu, Jie6 (AUTHOR), Zhang, Yawei7 (AUTHOR), Bian, Fang8 (AUTHOR), Zhang, Fang9 (AUTHOR), Liu, Weijuan10 (AUTHOR), Wu, Xiaohong11 (AUTHOR), Tang, Xulei12 (AUTHOR), Wang, Yihua13 (AUTHOR), Ning, Tao14 (AUTHOR), Pang, Shuguang15 (AUTHOR), Li, Ya16 (AUTHOR), Wang, Lijun17 (AUTHOR), Sun, Jia18 (AUTHOR), Hu, Honglin19 (AUTHOR)
Source: Journal of Diabetes Research. 3/23/2026, Vol. 2026, p1-7. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23146745
DOI:10.1155/jdr/2960736